UNSPSC 51391711: Cinnamedrine

This classification denotes an adrenergic agonist with the molecular formula C19H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1245J8012, chemically known as benzenemethanol, alpha-(1-(methyl(3-phenyl-2-propenyl)amino)ethyl)- but generally known as cinnamedrine, which bears US NIH Compound Identifier 5370611. European Medicines Agency schedules Cinnamedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06301MIG.

UNSPSC 51391711 Cinnamedrine, a Commodity code, does not map to the state and local procurement activity currently posted under this classification. The two recent opportunities tagged to this code both concern pharmaceutical procurement — one solicitation for naloxone and drug deactivation systems, the other a market-intelligence request about direct-to-manufacturer prescription programs — neither of which aligns with the nominal scope of cinnamedrine, a sympathomimetic drug used historically as a respiratory and circulatory stimulant. State and local governments do not appear to be soliciting cinnamedrine as a standalone procurement line item at present.

The mismatch between code and opportunity suggests either a data-entry error in the tagging of these solicitations or a drift in how the code is being applied by issuing bodies. Seminole County, Florida (IFB 60459723LAS, response deadline July 26, 2023) and the Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) are the only recent issuers shown, and neither is seeking cinnamedrine specifically. Practitioners evaluating this code should monitor whether future opportunities clarify the actual pharmaceutical categories state and local governments intend to procure under this commodity classification, or whether the code remains dormant for practical state and local purchasing purposes.